Shen, Sui <br/><br/>
Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma.  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Jan 2010 
 - 150-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-5667 
<br/><br/><label>Standard No.: </label>10.2967/jnumed.109.066597  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD20--metabolism<br/>Antineoplastic Agents--administration & dosage<br/>Combined Modality Therapy<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Indium Radioisotopes--pharmacokinetics<br/>Isotope Labeling<br/>Lymphoma, Non-Hodgkin--diagnostic imaging<br/>Organ Size--physiology<br/>Positron-Emission Tomography<br/>Radiometry<br/>Radiopharmaceuticals--pharmacokinetics<br/>Rituximab<br/>Tomography, X-Ray Computed<br/>Yttrium Radioisotopes